Answer
Regeneron Pharmaceuticals, a biotechnology company co-founded by Alfred G. Gilman, is dedicated to discovering, developing, and commercializing medicines for serious diseases. With a commitment to cutting-edge science and patient-centered innovation, Regeneron has an impressive track record of bringing transformative treatments to patients in areas such as oncology, inflammation, ophthalmology, and more.